According to prior research, Rg3 also reduced PD-L1 expression by inhibiting NF-κB p65 and Akt, which restored T cell cytotoxicity against cancer cells and reduced A549/DDP cells’ resistance to cisplatin therapy [225]. Here, AKT1 is linked to cancer.